Hypertension, antihypertensive medication use, and risk of psoriasis.

Association between Psoriasis Vulgaris and Coronary Heart Disease in a Hospital-Based Population in Japan. PLoS One (2016) 1.40

Patient with terbinafine-induced subacute cutaneous lupus erythematosus followed by thalidomide-induced orofacial neuropathy; Beta blocker use, hypertension, and the risk of psoriasis; eczematous reaction to intravenous immunoglobulin; nicolau syndrome after intra-articular glucocorticoid injection; troponin leak associated with drug-induced methemoglobinemia. Hosp Pharm (2015) 0.80

Balancing the cardiovascular risk and dermatologic hazard in patients with hypertension. JAMA Dermatol (2014) 0.75

Impact of metabolic status on the incidence of psoriasis: a Korean nationwide cohort study. Sci Rep (2017) 0.75

Exploring the Physiological Link between Psoriasis and Mood Disorders. Dermatol Res Pract (2015) 0.75

Management of the psychological comorbidities of dermatological conditions: practitioners' guidelines. Clin Cosmet Investig Dermatol (2017) 0.75

Psoriasis provoked or exacerbated by medications: identifying culprit drugs. JAMA Dermatol (2014) 0.75

Under pressure. Cutis (2014) 0.75

Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol (1986) 10.84

Risk of myocardial infarction in patients with psoriasis. JAMA (2006) 9.42

Psoriasis. N Engl J Med (2005) 8.56

Pathogenesis and therapy of psoriasis. Nature (2007) 6.94

Pathogenesis and clinical features of psoriasis. Lancet (2007) 5.01

Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol (2006) 4.12

The risk of stroke in patients with psoriasis. J Invest Dermatol (2009) 2.97

Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res (2006) 2.67

The direct cost of care for psoriasis and psoriatic arthritis in the United States. J Am Acad Dermatol (2002) 2.40

The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol (1999) 2.31

Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol (2009) 1.91

The relationship between inflammation, obesity and risk for hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA). J Hum Hypertens (2010) 1.86

Triggering psoriasis: the role of infections and medications. Clin Dermatol (2007) 1.58

Association between psoriasis and the metabolic syndrome. A cross-sectional study. Dermatology (2008) 1.53

Development and pilot-testing of a psoriasis screening tool. Br J Dermatol (2009) 1.41

The mechanism of lithium and beta-blocking agents in inducing and exacerbating psoriasis. J Drugs Dermatol (2006) 1.34

Psoriasis and risk of nonfatal cardiovascular disease in U.S. women: a cohort study. Br J Dermatol (2012) 1.26

The immune system: role in hypertension. Can J Cardiol (2012) 1.20

Drug induced psoriasis. Acta Dermatovenerol Croat (2011) 1.20

Psoriasis and risk of type 2 diabetes among women and men in the United States: a population-based cohort study. J Invest Dermatol (2011) 1.14

Psoriasis and hypertension: a case-control study. Acta Derm Venereol (2010) 1.12

Biomarkers of inflammation and endothelial dysfunction and risk of hypertension among Inner Mongolians in China. J Hypertens (2010) 1.00

Psoriasis and hypertension severity: results from a case-control study. PLoS One (2011) 0.98

Psoriasis in France and associated risk factors: results of a case-control study based on a large community survey. Dermatology (2008) 0.93

Drug-provoked psoriasis: is it drug induced or drug aggravated?: understanding pathophysiology and clinical relevance. J Clin Aesthet Dermatol (2010) 0.92

Nebivolol and metoprolol: long-term effects on inflammation and oxidative stress in essential hypertension. Scand J Clin Lab Invest (2012) 0.91

Association between beta-blockers, other antihypertensive drugs and psoriasis: population-based case-control study. Br J Dermatol (2008) 0.90

Calcium channel blockers intake and psoriasis: a case-control study. Acta Derm Venereol (2002) 0.89

Drug exposure and psoriasis vulgaris: case-control and case-crossover studies. Acta Derm Venereol (2005) 0.89

In the clinic. Psoriasis. Ann Intern Med (2011) 0.88

Exacerbation of psoriasis with beta-blocker therapy. CMAJ (2009) 0.85

Tyrosine phosphorylation in psoriatic T cells is modulated by drugs that induce or improve psoriasis. Dermatology (1995) 0.84

Psoriasis and hypertension: a case-control study. J Eur Acad Dermatol Venereol (2011) 0.83